Financial burden after surgery for bone and soft tissue sarcoma
Official title: Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Run by M.D. Anderson Cancer Center · NCT07215611 · Data updated 2026-11-12
This project will see how much financial stress people who have surgery for bone or soft tissue sarcoma face and how that stress affects their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 2, 2025 |
| Main results expected | October 2, 2028 |
| Study ends | October 2, 2030 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07215611 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult orthopedic oncology patients seen preoperatively at MD Anderson for resection of a primary malignant bone or soft tissue tumor who can read and write English.
✕Probably not a fit
Non-English speakers, pediatric patients, people treated outside MD Anderson, or those not undergoing surgical resection would not be eligible and therefore would not directly benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will measure the prevalence and severity of financial toxicity in adult patients undergoing surgical treatment for primary malignant bone or soft tissue tumors using a validated instrument. Investigators will collect demographic, socioeconomic, clinicopathologic, and treatment-related data from patients seen preoperatively at a single tertiary cancer center. Secondary objectives include identifying socioeconomic and demographic risk factors and clinicopathologic features associated with greater financial stress. All participants must be English-literate and treated at the enrolling site.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify patients at high risk for financial hardship and guide programs or policy changes to reduce financial stress and protect quality of life.
How similar studies have gone: Prior oncology research has repeatedly documented financial toxicity with validated tools and linked it to worse quality of life, though focused work specifically in orthopedic oncology is less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified. * Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor. Exclusion Criteria • Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.
Where it's running
-
MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Shalin S Patel, MD — M.D. Anderson Cancer Center
- Study coordinator: Shalin S Patel, MD
- Email: sspatel@mdanderson.org
- Phone: 713-792-6268
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hybrid AI chatbot for financial help in rural cancer care
A randomized pilot tests whether a hybrid chatbot provides better financial information and support for rural cancer patients and caregivers than an AI-enabled chatbot.
-
Oncology financial navigation offered as part of routine care
This project will try offering financial navigation as part of routine cancer care at UAB to see if it reduces patients' financial hardship and improves quality of life and distress.
-
Proactive Costs of Care support for people with gynecologic cancer
This one-time, 30-minute educational session tries to help adults with gynecologic cancer (or their caregivers) who are starting a new systemic therapy learn to track medical costs, understand insurance and resources, and reduce financial stress.
-
Zanzalintinib for advanced or metastatic bone sarcomas (ZAMBONE)
This study will see if zanzalintinib can slow disease progression in adults with advanced or metastatic bone sarcomas.
-
Exploring the needs and quality of life in advanced cancer patients receiving immunotherapy
This study looks at how advanced cancer patients on immunotherapy are doing physically and mentally to see if their needs are being met and how their quality of life can be improved.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.